Urothelial bladder cancer in young versus older adults: Presentations, clinical characteristics, and outcomes

Tarq Aziz Toma

doi:10.15218/zjms.2022.004

Authors

Tarq Aziz Toma Department of Surgery, College of Medicine, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2022.004

Keywords:

Urothelial bladder carcinoma, Age, Erbil, Iraq, Breech presentation

Abstract

Background and objective: Urothelial bladder carcinoma is a common malignancy but rarely occurs at young ages and can occur more frequently in the older group. The majority of bladder cancer consist of urothelial bladder carcinoma. This study aimed to review the clinical presentation, histopathological features, staging, grading, and the progression and recurrence of urothelial bladder cancer in patients aged below 40 years compared with older patients.

Methods: We retrospectively analyzed and reviewed 105 newly diagnosed patients with urothelial bladder carcinoma between August 2014 to January 2020 in a private clinic and Rizgary Teaching Hospital, Erbil city, Iraq.

Results: The mean age ± SD of the cases was 56.2 ± 19.37 years, ranging between 18 – 85 years. Patients were divided according to age into two main groups, Group I (29 patients) were aged ≤ 40 years, and Group II (76 patients) were above 40 years. Most cases (72.4%) were males, but there was no significant gender distribution difference between the two groups (P = 0.327). Gross hematuria was the most common presenting symptom in both groups. In Group I, the proportion of patients who ever smoked was 79.3%, and 47.4% in Group II (P = 0.003).A significantly higher proportion of patients with lower grade and stage and small tumor size was detected in Group I than in Group II (P <0.05). The recurrence rate of Group II (36.8%) was significantly higher than that (6.9%) of Group I (P = 0.002).

Conclusion: Urothelial bladder carcinomas among young patients were of lower grade, stage, and size than in older patients. The recurrence rate was higher among the older patients.

Metrics

Metrics Loading ...

References

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: A global overview and recent trends. Eur Urol. 2017;71(1):96–108. https://doi.org/10.1016/j.eururo.2016.06.010.

American Cancer Society. Cancer facts & figures 2017. (Accessed February, 3, 2021, at https://www.cancer.org/research/cancer-factsstatistics/all-cancer-facts-figures/cancer-facts-figures-2017.html).

Kates M, Bivalacqua TJ. Tumors of the bladder. In: Partin AW, editor. Campbell-Walsh- Wein. 12th ed. Philadelphia: Elsevier; 2020. P. 3073–90.

Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–41. https://doi.org/10.1016/j.eururo.2012.07.033.

Cumberbatch MG, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–95. https://doi.org/10.1016/j.eururo.2018.09.001.

Wen YC, Kuo JY, Chen KK, Lin AT, Chang YH, Hsu YS, et al. Urothelial carcinoma of the urinary bladder in young adults – Clinical experience at Taipei Veterans General Hospital. J Chin Med Assoc. 2015;68:272–5. https://doi.org/10.1016/S1726-4901(09)70149-2.

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA: A Cancer Journal for Clinicians. 2010;60(5):277–300.

Paner GP, Zehnder P, Amin AM, Husain AN, Desai MM. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol. 2013;18(1):79–89. https://doi.org/10.1097/PAP.0b013e318204c0cf.

Zabell J, Konety BR. Management strategies for non–muscle-invasive bladder cancer (Ta, T1, and CIS). In: Partin AW, editor. Campbell-Walsh-Wein. 12th ed. Philadelphia: Elsevier; 2020. P. 3091–111.

Shi B, Zhang K, Zhang J, Chen J, Zhang N, Xu Z. Relationship between patient age and superficial transitional cell carcinoma characteristics. Urology. 2008;71(6):1186–90. https://doi.org/10.1016/j.urology.2008.01.062.

Gunlusoy B, Ceylan Y, Degirmenci T, Kozacioglu Z, Yonguc T, Bozkurt H, et al. Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour. Can Urol Assoc J. 2015;9(9–10):E727–30. https://doi.org/10.5489/cuaj.3049.

Cumberbatch MG, Noon AP. Epidemiology, aetiology and screening of bladder cancer. Translational Andrology and Urology. 2019;8(1):5. https://doi.org/10.21037/tau.2018.09.11

Islami F, Stoklosa M, Drope J,Jemal A. Global and regional patterns of tobacco smoking and tobacco control policies. Eur Urol Focus. 2015;1:3–16. https://doi.org/10.1016/j.euf.2014.10.001.

Obeyed H. Iraqi cancer registry. Annual report. Iraq; 2016.

Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. John Wiley & Sons; 2011.

Mostofi FK, Sobin LH, Torloni H, World Health Organization. Histological typing of urinary bladder tumours. World Health Organization; 1973.

Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. The Journal of Urology.1983;130(6):1083–6.

Palumbo C, Pecoraro A, Rosiello G, Luzzago S, Deuker M, Stolzenbach F, et al. Bladder cancer incidence rates and trends in young adults aged 20-39 years. Urologic Oncology: Seminars and Original Investigations. 2020;38(12):934.e11–9. https://doi.org/10.1016/j.urolonc.2020.06.009.

Gunlusoy B, Ceylan Y, Degirmenci T, Aydogdu O, Kozacioglu Z. The potential effect of age on the natural behavior of bladder cancer: Does urothelial cell carcinoma progress differently in various age groups? The Kaohsiung Journal of Medical Sciences. 2016;32(5):261–6. https://doi.org/10.1016/j.kjms.2016.03.002.

Compérat E, Larré S, Roupret M, Neuzillet Y, Pignot G, Quintens H, et al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch. 2015;466:589–94. https://doi.org/10.1007/s00428-015-1739-2.

Gunlusoy B, Ceylan Y, Degirmenci T, Kozacioglu Z, Yonguc T, Bozkurt H, et al. Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour. Can Urol Assoc J. 2015;9(9–10):E727–30. https://doi.org/10.5489/cuaj.3049.

Kosko K. Age at menopause may play a role in bladder cancer risk cure 2019. (Accessed February, 16, 2021, at https://www.curetoday.com/view/age-at-menopause-may-play-a-role-in-bladder-cancer-risk).

Kang M, Ku JH. The role of androgen receptor signaling pathways in bladder cancer. Translational Cancer Research. 2017;6:S702–7.

Greenfield SP, Williot P, Kaplan D. Gross hematuria in children: a ten-year review. Urology. 2007;69:166–9. https://doi.org/10.1016/j.urology.2006.10.018.

Alabdulkareem AI, Al-Jahdali FH, Nazers AI, Alkhateeb SS. Characteristics of bladder neoplasms in the young population of Saudi Arabia. Urology Annals. 2017;9(4):343. https://doi.org/10.4103/UA.UA_122_17.

Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737–45. https://doi.org/10.1001/jama.2011.1142.

Fernandez-Gomez J, Solsona E, Unda M, Martinez-Piñeiro L, Gonzalez M, Hernandez R, et al. Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials. Eur Urol. 2008;53(5):992–1001. https://doi.org/10.1016/j.eururo.2007.10.006.

Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol. 2004;22(2):86–92. https://doi.org/10.1016/S1078-1439(03)00139-X.

Van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol. 2009;56(3):430–42. https://doi.org/10.1016/j.eururo.2009.06.028.